On Monday, Tandem Diabetes Care Inc (TNDM) stock saw a modest uptick, ending the day at $31.37 which represents a slight increase of $0.77 or 2.52% from the prior close of $30.6. The stock opened at ...

Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price boosted by Barclays from $58.00 to $60.00 in a research ...

Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

Tandem Diabetes Care, Inc. TNDM posted a third-quarter 2024 loss of 36 cents per share compared with the year-ago quarter’s ...

Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its price objective lowered by Canaccord Genuity Group from $57.00 to ...

Tandem Diabetes Care shares ticked up after hours today on third-quarter results that topped the consensus forecast.

On Friday, Tandem Diabetes Care Inc (TNDM) stock saw a decline, ending the day at $30.6 which represents a decrease of $-2.72 or -8.16% from the prior close of $33.32. The stock opened at $33.71 and ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

In the last three months, 5 analysts have published ratings on Tandem Diabetes Care (NASDAQ:TNDM), offering a diverse range of perspectives from bullish to bearish. The table below provides a ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Waters (WAT – Research Report), Pharvaris ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Good day and thank you for standing by. Welcome to the Tandem Diabetes Care Q3 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Please be advised that today ...